iBio, Inc. (IBIO) vs Telomir Pharmaceuticals, Inc. (TELO)
iBio, Inc. and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. iBio, Inc. and Telomir Pharmaceuticals, Inc. are of similar size ($83.2M and $77.3M). Across the 9 metrics below, iBio, Inc. leads on 6 and Telomir Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | IBIO | TELO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (65.70%) | (1,885.50%) | (57.72%) |
| Return on assets | (54.04%) | (1,678.31%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack